Hiperbarinė deguonies terapija, MB - financials and debts
Company age: 3 y. 11 mo.
Hiperbarinė deguonies terapija - Company finances
|
EUR
|
2022
From: 2022-10-07
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | - | 22,462 | 33,932 | 51,696 |
| Profit before tax | 0 | -458 | -6,379 | -11,005 |
| Net profit | 0 | -458 | -6,379 | -11,005 |
| Equity | 1 | 6,842 | 463 | -10,542 |
| Liabilities | 10 | 47,211 | 41,864 | 40,822 |
| Non-current assets | 0 | 51,903 | 40,274 | 28,646 |
| Current assets | 11 | 2,150 | 2,053 | 1,634 |
| Total assets | 11 | 54,053 | 42,327 | 30,280 |
|
Taxes paid
|
||||
| STI taxes | - | - | 2,974 | 6,591 |
|
Financial indicators
|
||||
| Revenue change y/y | - | - | +51.1% | +52.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | -0.8% | -15.1% | -36.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | -6.7% | -1377.8% | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | -2.0% | -18.8% | -21.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | -2.0% | -18.8% | -21.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 10.0 | 6.9 | 90.4 | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | 51,696 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Hiperbarinė deguonies terapija - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-10-03 | 2023-10-31 | 175.89 |
| 2023-09-01 | 2023-10-02 | 117.26 |
| 2023-08-01 | 2023-08-31 | 58.63 |
Hiperbarinė deguonies terapija - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Hiperbarinė deguonies terapija is: 0 €
| From | To | Overdue, € |
|---|---|---|
| 2026-08-28 | 2026-09-02 | 0.14 |
| 2025-02-28 | 2025-03-24 | 0.08 |
| 2025-01-01 | 2025-01-23 | 0.06 |
| 2024-11-28 | 2024-12-29 | 0.03 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Hiperbarine deguonies terapija, MB (code 306156468) is a Small partnership operating in Medical specialists activities. In 2025, the company generated revenue of €51.7K, up 52.4% year on year and 130.2% over two years. Despite stronger turnover, profitability remained negative: net loss reached €11.0K, compared with a loss of €6.4K in 2024 and €458 in 2023. The 2025 profit margin was -21.3%, showing that revenue growth did not translate into earnings. The balance sheet weakened during the period, with total assets declining to €30.3K from €42.3K in 2024 and €54.1K in 2023. Equity turned negative at -€10.5K in 2025, while liabilities stood at €40.8K. Long-term assets were €28.6K and short-term assets €1.6K. Asset turnover was 1.71x, indicating relatively high revenue generation from the asset base, while revenue per employee was €51.7K and profit per employee was -€11.0K. Profitability ratios should be interpreted cautiously because the negative equity base distorts return measures in 2025.